Global Fund delays closing date for round 11 applications, says disbursements may not be available until 2013

NewsGuard 100/100 Score

The Global Fund to Fight HIV, TB and Malaria has delayed the closing date for applications for its next round of funding, reduced the estimated amount of money that will be available in that round, and potentially delayed the disbursement of the funds until 2013, PlusNews reports. "The delay in Round 11 funding was announced at the Fund's latest board meeting on 26 September, the second such delay, which has pushed the application deadline back to at least 1 March 2012," the news service notes.

PlusNews examines potential reasons for the reduction in estimated funding. "The size of the pot has ... shrunk -- to US$800 million, ... according to Christoph Benn, director of the Fund's external relations and partnerships." The news service writes, "The newly revised estimates for Round 11 also take into account the emergency funding that as many as 10 countries, many in Africa, will need to continue what the Fund terms 'lifesaving' interventions until the Round 11 2013 disbursement, according to Benn" (11/8).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New malaria vaccine strain shows promise in preclinical trials